Alnylam Pharmaceuticals Pre-Paid Expenses 2010-2024 | ALNY
- Alnylam Pharmaceuticals pre-paid expenses for 2024 were $0.117B, a 7.45% decline from 2023.
- Alnylam Pharmaceuticals pre-paid expenses for 2023 were $0.126B, a 4.92% decline from 2022.
- Alnylam Pharmaceuticals pre-paid expenses for 2022 were $0.133B, a 50.91% increase from 2021.